Oct 2026· Frontiers in Microbiology· Vol 17· 0 citations· 43 references
Medicine
TL;DR
The recombinant depolymerase Dep_Zy was characterized, which exhibited potent depolymerase and antibiofilm activities, and was highlighted as a promising enzymatic strategy for controlling multidrug-resistant Klebsiella pneumoniae through biofilm disruption and antibiotic potentiation.
Abstract
Understanding phage K. pneumoniae–host interactions is essential for elucidating phage infection mechanisms and developing phage-derived antibacterial strategies. This showed that lipopolysaccharide (LPS) plays an important role in phage vB_KpnS_MK54 adsorption by constructing the isogenic deletion mutants LPKPΔmsbA and LPKPΔlpxB, in which phage adsorption was reduced by 2–3 log compared with the wild-type strain. Biofilms are associated with persistent infections and increased tolerance to antimicrobial treatment, posing a significant clinical challenge. We further characterized the recombinant depolymerase Dep_Zy, which exhibited potent depolymerase and antibiofilm activities, including depolymerase activity at 0.1 μg/mL, 55% inhibition of biofilm formation at 10 μg/mL, and 30% degradation of mature biofilms at 1 μg/mL. Notably, Dep_Zy potentiated the activity of conventional antibiotics, resulting in a 1–3 log reduction in biofilm-associated bacterial counts when combined with kanamycin, gentamicin, or streptomycin. These findings elucidate the molecular basis of phage–host interactions and highlight Dep_Zy as a promising enzymatic strategy for controlling multidrug-resistant Klebsiella pneumoniae through biofilm disruption and antibiotic potentiation.
Phage-derived depolymerases are promising antibiofilm enzymes. In this study, intact and disintegrated GADU21 phage were first tested for their ability to disrupt mature biofilm using the crystal violet assay. Disintegrated phage was more active on biofilms than intact phage. The dp21 gene encoding the depolymerase was...
Hanife Salih Doğan, Gülistan Asya Orbayoğlu, A. Karaynir et al.· Biofouling (Print)· 0 citations
The increasing prevalence of multidrug-resistant (MDR) Klebsiella pneumoniae and its capacity to form persistent biofilms highlight the need for alternative antimicrobial strategies. This study characterised the lytic bacteriophage vB_KpnS_Tech (PQ859379.1) and evaluated its activity in combination with meropenem again...
Kashif Haq, Martin Figgitt, David Lee et al.· International Microbiology· 0 citations
Bacteriophage therapy is a promising strategy against multidrug-resistant (MDR) extraintestinal pathogenic Escherichia coli (ExPEC), yet bacterial resistance evolution remains a major clinical challenge. In this study, we isolated and comprehensively characterized a novel lytic phage, vB_EcoP_P61425, belonging to the g...
Long Chen, Si-Xiang Xu, Xiao-Yue Li et al.· Frontiers in Microbiology· 0 citations
ABSTRACT Temperate phages are increasingly recognized as key drivers of bacterial evolution. Here, we isolated a myoviral prophage, vB_EcoM_P899, from a clinical uropathogenic Escherichia coli (UPEC) isolate and characterized how lysogenization shapes host biology. Lysogenization significantly enhanced biofilm formatio...
Bo Yan, Can Yan, Qing-Wen Li et al.· Applied and Environmental Mi...· 0 citations
This study studied ORF55, a tail fiber protein from Pseudomonas phage phiPA1-3 that contains an SGNH hydrolase domain, and generated two highly stable tools: a potent enzyme to eradicate multidrug-resistant biofilms and a sensitive diagnostic probe for rapid pathogen detection.
Multidrug-resistantKlebsiella pneumoniae has emerged as a formidable healthcare challenge, driving the urgent need for alternative therapeutic strategies such as phage therapy. In this study, we isolated and comprehensively characterized a novel phage, designated vB_Kp_IME328 (IME328), which exhibits highly specific ba...
Can Wang, Rui-Lin Yang, Jin-Pan Wei et al.· Folia Microbiologica (Prague...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.